Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD32b/FCGR2B Protein, C-His

Catalog #:   EHD97901 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian Cells
Accession: P31994
Protein length: Thr43-Pro217
Overview

Catalog No.

EHD97901

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Thr43-Pro217

Predicted molecular weight

22.51 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P31994

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

IGFR2, FCG2, Fc-gamma RII-b, CDw32, FcRII-b, IgG Fc receptor II-b, CD32, Fc-gamma-RIIb, Low affinity immunoglobulin gamma Fc region receptor II-b, FCGR2B

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CD32b/FCGR2B Protein
  • Bioactivity
    Detects SM201 in indirect ELISAs.
References

Human Fcγ-receptors selectively respond to C-reactive protein isoforms., PMID:40458392

Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection., PMID:40197366

Macrophage-derived Fgl2 dampens antitumor immunity through regulation of FcγRIIB+CD8+ T cells in melanoma., PMID:40125553

FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs., PMID:40089806

Fc gamma receptors activate different protein kinase C isoforms in human neutrophils., PMID:39946245

Protection of liver sinusoidal endothelial cells using different preservation solutions., PMID:39812559

A Competition-Based Strategy for the Isolation of an Anti-Idiotypic Blocking Module and Fine-Tuning for Conditional Activation of a Therapeutic Antibody., PMID:39655405

The Immunosuppressive Receptor CD32b Regulation of Macrophage Polarization and Its Implications in Tumor Progression., PMID:39273683

FGL2/FcγRIIB Signalling Mediates Arterial Shear Stress-Mediated Endothelial Cell Apoptosis: Implications for Coronary Artery Bypass Vein Graft Pathogenesis., PMID:39062880

A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia., PMID:38899695

New candidate SNPs for genetic association with Alzheimer's disease: a linkage disequilibrium analysis for the FCGRIIB and PILRA genes., PMID:38408113

Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding., PMID:38050338

Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational study., PMID:37789648

FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis., PMID:37713871

FcγRIIB expressed on CD8+ T cells limits responsiveness to PD-1 checkpoint inhibition in cancer., PMID:37611081

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab., PMID:37575254

Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases., PMID:37569282

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up., PMID:36972491

CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study., PMID:36929282

The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells., PMID:36822164

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy., PMID:36685519

Two major genes associated with autoimmune arthritis, Ncf1 and Fcgr2b, additively protect mice by strengthening T cell tolerance., PMID:35963953

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms., PMID:35858562

The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury., PMID:35784350

Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma., PMID:35610242

Role of Fcγ receptors in HER2-targeted breast cancer therapy., PMID:34992090

Aberrant expression of inhibitory receptors on B cells in patients with Graves' disease., PMID:34933777

Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index., PMID:34922596

The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells., PMID:34899053

Evaluation of the FCGR2B polymorphism in children with immune thrombocytopenia., PMID:34859644

Similarity and Potential Relation Between Periimplantitis and Rheumatoid Arthritis on Transcriptomic Level: Results of a Bioinformatics Study., PMID:34858391

An Afucosylated Anti-CD32b Monoclonal Antibody Induced Platelet-Mediated Adverse Events in a Human Fcγ Receptor Transgenic Mouse Model and Its Potential Human Translatability., PMID:34687301

Homogeneously high expression of CD32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia., PMID:34530888

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment., PMID:34323958

Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma., PMID:34267181

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels., PMID:34192382

FCGR Genetic Variation in Two Populations From Ecuador Highlands-Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) Gene., PMID:34108956

Blocking FcγRIIB in Smooth Muscle Cells Reduces Hypertension., PMID:33980031

Sevoflurane induces inflammation of microglia in hippocampus of neonatal rats by inhibiting Wnt/β-Catenin/CaMKIV pathway., PMID:33941321

Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu., PMID:33893391

Margetuximab: First Approval., PMID:33761116

FcγRIIB is a T cell checkpoint in antitumor immunity., PMID:33616086

Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis., PMID:33568400

FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis., PMID:33505402

PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells., PMID:33446637

Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes., PMID:33424774

Yishen-tongbi decoction inhibits excessive activation of B cells by activating the FcγRIIb/Lyn/SHP-1 pathway and attenuates the inflammatory response in CIA rats., PMID:33373915

IgE and mast cells: The endogenous adjuvant., PMID:33190734

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys., PMID:33188207

DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy., PMID:32956626

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD32b/FCGR2B Protein, C-His [EHD97901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only